Trial Profile
Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation by Using Recombinant Luteinizing Hormone (rLH) and Recombinant Follicle Stimulating Hormone (rFSH) in Patients With Hypogonadotropic Hypogonadism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary) ; Lutropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 22 Feb 2018 Status changed from recruiting to completed.
- 25 Jul 2014 New trial record